Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetes
- 1 July 1984
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 35 (1) , 19-25
- https://doi.org/10.1016/0049-3848(84)90309-8
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Diabetic retinopathy and the fibrinolytic systemDiabetes, 1975
- On Fibrinolysis in Diabetes MellitusActa Medica Scandinavica, 1975
- INCREASED VON WILLEBRAND‐ANTIHAEMOPHILIC FACTOR A IN DIABETIC RETINOPATHYActa Ophthalmologica, 1974
- FIBRINOLYTIC ACTIVITY OF HUMAN VEINSThe Lancet, 1967
- Automated Techniques in Lipid ChemistryPublished by Elsevier ,1967
- Determination of α2-macroglobulin as trypsin-protein esteraseClinica Chimica Acta; International Journal of Clinical Chemistry, 1966
- A Method for Determining Serum Inhibitors of Plasminogen ActivationScandinavian Journal of Clinical and Laboratory Investigation, 1962
- EFFECT OF THE SULPHONYLUREAS ON FIBRINOLYSISThe Lancet, 1960
- The histological localisation of fibrinolysin activatorThe Journal of Pathology and Bacteriology, 1959
- An improved glucose-oxidase method for determining blood C.S.F. and urine glucose levelsClinica Chimica Acta; International Journal of Clinical Chemistry, 1959